Testing 3 biomarkers to detect prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial is studying three biomarkers (substances in your body) to see if they can help detect prostate cancer. If you are being checked for possible prostate cancer or are on active surveillance, this study may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man 18 years or older.
- You are being evaluated for possible prostate cancer or are on active surveillance for prostate cancer.
- You are able to give consent to be in the study.
- You do not have an active urinary tract infection.
- You have not had any other cancer or are not currently receiving cancer treatment (including hormone therapy for prostate cancer).
- You have not been in another study with an investigational drug in the last 4 months and are not currently enrolled in one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new biological markers in men to improve how prostate cancer is diagnosed and followed. If you have signs that might be prostate cancer, your tests may help researchers find better clues for future care.
This study collects and measures “biomarkers” (measurable signs in the body) from people with prostate cancer who are about to have surgery or radiation. The goal is to understand how prostate cancer behaves during treatment, which may help improve care in the future.
This study looks for new urine markers (signals) that could help screen for prostate cancer. If you have a higher PSA blood test and are scheduled for a prostate biopsy, your urine sample may be studied to see if it can improve screening.
This study checks whether certain blood markers can help predict how well people with prostate cancer will respond to therapy. It may help doctors choose the most effective treatment sooner by using information from your blood.
This study collects a small urine sample around the time of a prostate biopsy to look for chemical “signals” that may explain dangerous prostate cancer behavior. Your results are not shared with you, but the information may help researchers improve understanding and future care.
This study uses a blood test to detect prostate cancer more accurately than traditional methods. It looks for genetic material from cancer cells to help decide if a prostate biopsy is needed.
Hear when a new Cancer of Prostate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.